AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Debt to Equity Ratio : 0.7166 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.7166 |
| December 31, 2025 | 0.6087 |
| September 30, 2025 | 0.7111 |
| June 30, 2025 | 0.7343 |
| March 31, 2025 | 0.7711 |
| December 31, 2024 | 0.7428 |
| September 30, 2024 | 0.7751 |
| June 30, 2024 | 0.8487 |
| March 31, 2024 | 0.9227 |
| December 31, 2023 | 0.7312 |
| September 30, 2023 | 0.7682 |
| June 30, 2023 | 0.798 |
| March 31, 2023 | 0.8802 |
| December 31, 2022 | 0.7893 |
| September 30, 2022 | 0.8339 |
| June 30, 2022 | 0.8218 |
| March 31, 2022 | 0.8558 |
| December 31, 2021 | 0.7839 |
| September 30, 2021 | 0.8029 |
| June 30, 2021 | 1.754 |
| March 31, 2021 | 1.395 |
| December 31, 2020 | 1.305 |
| September 30, 2020 | 1.832 |
| June 30, 2020 | 1.614 |
| March 31, 2020 | 1.724 |
| Date | Value |
|---|---|
| December 31, 2019 | 1.388 |
| September 30, 2019 | 1.493 |
| June 30, 2019 | 1.454 |
| March 31, 2019 | 2.058 |
| December 31, 2018 | 1.533 |
| September 30, 2018 | 1.752 |
| June 30, 2018 | 1.555 |
| March 31, 2018 | 1.537 |
| December 31, 2017 | 1.190 |
| September 30, 2017 | 1.301 |
| June 30, 2017 | 1.445 |
| March 31, 2017 | 1.340 |
| December 31, 2016 | 1.132 |
| September 30, 2016 | 1.353 |
| June 30, 2016 | 1.299 |
| March 31, 2016 | 1.107 |
| December 31, 2015 | 0.8141 |
| September 30, 2015 | 0.631 |
| June 30, 2015 | 0.6022 |
| March 31, 2015 | 0.6241 |
| December 31, 2014 | 0.5525 |
| September 30, 2014 | 0.4855 |
| June 30, 2014 | 0.4573 |
| March 31, 2014 | 0.482 |
| December 31, 2013 | 0.4468 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| GSK Plc | 1.034 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| Merck & Co., Inc. | 1.286 |
| Novo Nordisk A/S | 0.6333 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 114.02B |
| Total Liabilities (Quarterly) | 66.63B |
| Shareholders Equity (Quarterly) | 47.33B |
| Current Ratio | 0.9092 |
| Net Debt Paydown Yield | -0.12% |